新闻Cancer Genetics, Inc. partners with Novellusdx.For instance, cancer Genetics announced merger with NovellusDx as a result of which Cancer Genetics portfolio of oncology test and services will combine with next-generation sequencing and other technologies of NovellusDx.
新闻Cancer Genetics, Inc. launched proof-of-concept program on Sep 3rd '20.Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, and StemoniX, Inc., a company empowering the discovery of new medicines through the convergence of novel human biology and software technologies, today announced a joint proof-of-concept program.
新闻Cancer Genetics, Inc. merged with Stemonix on Sep 19th '20.Halper Sadeh LLP, a global investor rights law firm, is investigating whether Cancer Genetics, Inc. (NASDAQ: CGIX ) and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with Cancer Genetics's proposed merger with StemoniX, Inc.
